Category: medicine

Japanese flu drug appears ‘effective’ in coronavirus treatment in Chinese clinical trials

Japanese-made flu drug favipiravir (also known as Avigan) has been shown to be effective in both reducing the duration of the COVID-19 virus in patients, and to have improved the lung conditions of those who received treatment with the drug, based on results of clinical trials conducted with affected patients…

Read More

New study of COVID-19 patient’s immune response could inform future treatment

A new study published in science journal Nature Medicine (via Bloomberg) examines the case of a patient who contracted COVID-19 in Wuhan and fell ill in Melbourne, Australia could provide a more comprehensive view of how and why certain people react to the virus more seriously than others. The patient’s…

Read More

First U.S. clinical human trial of potential coronavirus vaccine set to start Monday

A human clinical trial of a potential vaccine for the new coronavirus will begin on Monday, the AP reports. The trial, which will test the effects of an experimental vaccine shot developed by the National Institutes of Health and drugmaker Moderna, won’t make use of either an active or inactive…

Read More

CDC issues new guidance against gatherings of 50 or more people for the next 8 weeks

The U.S. Centers for Disease Control and Prevention (CDC) has updated its guidance (also available in full below) regarding large group gatherings and events in light of the ongoing effort to combat the spread of coronavirus in the country. The new CDC guidance recommends against holding any events or group gatherings…

Read More

Noom competitor OurPath rebrands as Second Nature, raises $10M Series A

Back in 2018, OurPath emerged as a startup in the U.K. tackling the problem of diabetes. The company helped customers fight the disease, and raised a $3 million round of funding by combining advice from health experts with tracking technology via a smartphone app to help people build healthy habits…

Read More

California Senator proposes tighter regulations on direct-to-consumer genetics testing companies

A state senator in California is introducing legislation designed to provide more direct oversight over direct-to-consumer genetic testing companies. The new regulations, introduced by Santa Ana’s Democratic Senator Thomas Umberg, builds on attempts in the California Consumer Privacy Act to regulate the ways data collected from genetic testing can be…

Read More